Profile data is unavailable for this security.
About the company
Paragon Care Limited is an Australia-based company, which is engaged in the healthcare sector. The Company is a provider of medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional supplies, and manufacturer of Blood Bank diagnostic reagents to the healthcare markets in Australia, New Zealand and Asia. The Company’s geographical segments comprise Australia & New Zealand and Asia. It also offers equipment repair, maintenance and total equipment management through ParagonCare Service & Technology. Its CH2 brand distributes pharmaceutical, medical consumables, nutritional and over the counter products medical equipment and medical supplies. Its product portfolio includes critical care, dental, diagnostic & scientific, medical products & consumables, neonatal, orthopedics, service, surgical, technology & connectivity, urology, veterinary and aesthetics. Its brands include ParagonCare Immulab, ParagonCare Veterinary, Medtek, and Western Biomedical.
- Revenue in AUD (TTM)3.62bn
- Net income in AUD20.57m
- Incorporated1994
- Employees0.00
- LocationParagon Care LtdLevel 4, 96-100 Albert RoadSOUTH MELBOURNE 3205AustraliaAUS
- Phone+61 30036-9559
- Fax+61 38833-7890
- Websitehttps://paragoncare.com.au/contact
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMvision Medical Devices Ltd | 5.87m | -10.20m | 163.11m | -- | -- | 8.26 | -- | 27.80 | -0.1175 | -0.1175 | 0.0672 | 0.2124 | 0.2619 | -- | 1.29 | -- | -45.53 | -47.15 | -49.79 | -58.42 | -- | -- | -173.86 | -105.97 | -- | -60.90 | 0.150 | -- | -51.31 | 41.83 | -259.23 | -- | -- | -- |
| Lumos Diagnostics Holdings Ltd | 17.43m | -10.10m | 210.20m | -- | -- | 22.92 | -- | 12.06 | -0.0147 | -0.0147 | 0.0256 | 0.0116 | 0.5205 | 7.04 | 4.91 | -- | -30.15 | -40.19 | -54.60 | -61.16 | 62.95 | 52.57 | -57.93 | -132.46 | 0.6816 | -10.69 | 0.5315 | -- | 11.40 | 17.12 | 16.40 | -- | -61.58 | -- |
| Aroa Biosurgery Ltd | 76.20m | -1.53m | 228.01m | 261.00 | -- | 2.92 | 137.24 | 2.99 | -0.0044 | -0.0044 | 0.2208 | 0.2257 | 0.8432 | 1.56 | 3.08 | -- | -1.70 | -8.53 | -1.85 | -9.75 | 85.07 | 82.71 | -2.01 | -15.20 | 5.74 | 0.3142 | 0.0706 | -- | 22.63 | 27.56 | 64.12 | -- | 14.62 | -- |
| Orthocell Ltd | 8.85m | -8.57m | 248.25m | -- | -- | 15.28 | -- | 28.05 | -0.0375 | -0.0375 | 0.0397 | 0.0599 | 0.2862 | 2.31 | 9.20 | -- | -27.70 | -28.14 | -34.17 | -33.47 | 68.98 | 71.87 | -96.78 | -167.82 | 4.78 | -- | 0.0381 | -- | 36.41 | 61.65 | -19.30 | -- | 45.43 | -- |
| Saluda Medical Inc | -100.00bn | -100.00bn | 255.80m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 36.13 | -- | -52.62 | -- | -- | -- |
| EBR Systems Inc | 958.51k | -62.99m | 306.03m | -- | -- | 5.63 | -- | 319.27 | -0.1682 | -0.1682 | 0.0025 | 0.1208 | 0.0074 | -- | 0.4935 | -- | -48.75 | -60.71 | -53.75 | -74.76 | 45.20 | -- | -6,572.14 | -- | 7.01 | -15.00 | 0.5131 | -- | -- | -- | -16.44 | -- | 2.46 | -- |
| Paragon Care Ltd | 3.62bn | 20.57m | 322.78m | 0.00 | 15.70 | 0.9786 | 6.40 | 0.0892 | 0.0124 | 0.0124 | 2.18 | 0.1993 | 3.02 | 11.90 | 10.33 | -- | 1.72 | 1.79 | 4.47 | 4.07 | 9.04 | 8.90 | 0.5688 | 0.6081 | 0.6155 | 1.77 | 0.4699 | -- | 21.72 | 73.23 | 151.52 | -- | 18.34 | -- |
| EchoIQ Ltd | 101.41k | -13.26m | 412.91m | -- | -- | 17.86 | -- | 4,071.69 | -0.0226 | -0.0226 | 0.0002 | 0.0353 | 0.0064 | -- | 0.6446 | -- | -83.87 | -68.78 | -89.84 | -81.95 | -- | -- | -13,078.12 | -3,892.98 | -- | -- | 0.00 | -- | 127.89 | -31.65 | -145.19 | -- | -16.56 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Australian Ethical Investments Ltd. (Investment Management)as of 19 Dec 2025 | 113.70m | 6.87% |
| Wilson Asset Management (International) Pty Ltd.as of 19 Dec 2025 | 82.60m | 4.99% |
| MAM Pty Ltd.as of 30 Jun 2025 | 20.47m | 1.24% |
| First Samuel Ltd.as of 22 Sep 2025 | 14.76m | 0.89% |
| DFA Australia Ltd.as of 31 Jan 2026 | 5.01m | 0.30% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 2.16m | 0.13% |
| Vanguard Investments Australia Ltd.as of 31 Jan 2026 | 276.25k | 0.02% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 230.81k | 0.01% |
| Global X Management (AUS) Ltd.as of 05 Feb 2026 | 2.38k | 0.00% |
